Israel Englander Biomarin Pharmaceutical Inc Put Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$74.43 - $92.22 $1.32 Million - $1.64 Million
-17,800 Reduced 56.51%
13,700 $1.13 Million
Q1 2024

May 15, 2024
SELL
$83.81 - $99.0 $2.64 Million - $3.12 Million
-31,500 Reduced 50.0%
31,500 $2.75 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $4.8 Million - $6.21 Million
63,000 New
63,000 $6.07 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $11 Million - $14.7 Million
125,300 New
125,300 $12.2 Million

Others Institutions Holding BMRN

# of Institutions
621
Shares Held
183M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email